Gloria S Huang MD
Gynecologic Oncology
Associate Professor, Yale School of Medicine
Join to View Full Profile
Yale School of MedicineDepartment of Obstetrics, Gynecology and Reproductive SciencesNew Haven, CT 06520
Phone+1 203-785-7385
Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Gynecologic Oncology, 2002 - 2005
Stanford Health Care-Sponsored Stanford UniversityResidency, Obstetrics and Gynecology, 1997 - 2001
Stanford University School of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2022 - Present
CA State Medical License 1998 - 2026
CT State Medical License 2016 - 2025
NY State Medical License 2002 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow American Gynecological and Obstetrical Society (AGOS)
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Abemaciclib and Letrozole to Treat Endometrial Cancer Start of enrollment: 2020 Oct 10
Publications & Presentations
PubMed
- Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovaria...Levent Mutlu, Blair McNamara, Stefania Bellone, Diego D Manavella, Cem Demirkiran
Clinical & Experimental Metastasis. 2024-10-01 - 1 citationsARID1A in Gynecologic Precancers and Cancers.Jaida E Morgan, Nishah Jaferi, Zainab Shonibare, Gloria S Huang
Reproductive Sciences. 2024-08-01 - Randomized phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer (NCT030931...Dana M Roque, Eric R Siegel, Natalia Buza, Stefania Bellone, Gloria S Huang
BJC Reports. 2024-06-20
Press Mentions
Yale Doc: Throat, Neck Cancers Caused by HPV ‘Completely Preventable’ with VaccineMay 23rd, 2022- Yale Cancer Center Study Shows New Treatment Pathway to Prevent and Treat Endometrial Cancer RecurrenceFebruary 23rd, 2021
Ovarian Cancer? What You Need to Know About TreatmentOctober 6th, 2016
Professional Memberships
- Member
- Fellow
- Society of Gynecologic OncologyMember
- Member
- American Gynecological and Obstetrical SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
